We are live on ! Find out more
RXII

GALENA BIOPHARMA INC COM
RXII

Delisted

RXII was delisted on the 25th of October, 2011.

Back to rankings

85 hedge funds and large institutions have $44.3M invested in GALENA BIOPHARMA INC COM in 2014 Q3 according to their latest regulatory filings, with 14 funds opening new positions, 24 increasing their positions, 27 reducing their positions, and 17 closing their positions.

New
Increased
Maintained
Reduced
Closed

17% more call options, than puts

Call options by funds: $5.8M | Put options by funds: $4.94M

6% less funds holding

Funds holding: 90 → 85 (-5)

11% less repeat investments, than reductions

Existing positions increased: 24 | Existing positions reduced: 27

18% less first-time investments, than exits

New positions opened: 14 | Existing positions closed: 17

36% less capital invested

Capital invested by funds: $68.9M → $44.3M (-$24.7M)

Holders
85
Holders Change
-5
Holders Change %
-5.56%
% of All Funds
2.47%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
14
Increased
24
Reduced
27
Closed
17
Calls
$5.8M
Puts
$4.94M
Net Calls
+$857K
Net Calls Change
+$398K

Top Buyers

Rank Fund Capital Flow
1
Morgan Stanley
Morgan Stanley
New York
+$305K
2
BIT
BlackRock Institutional Trust
California
+$267K
3
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$258K
4
Group One Trading
Group One Trading
Illinois
+$248K
5
State Street
State Street
Massachusetts
+$172K

Top Sellers

Rank Fund Capital Flow
1
BCM
Bridgeway Capital Management
Texas
-$1.65M
2
Invesco
Invesco
Georgia
-$1.18M
3
D.E. Shaw & Co
D.E. Shaw & Co
New York
-$468K
4
BFA
BlackRock Fund Advisors
California
-$242K
5
LPL Financial
LPL Financial
California
-$155K
Name Holding Trade Value Shares
Change 		Change in
Stake
BlackRock
76
BlackRock
New York
$7K +$1.54K +782 +28%
KTC
77
Kistler-Tiffany Companies
Pennsylvania
$5K – – –
CLOS
78
Compagnie Lombard Odier SCmA
Switzerland
$4K – – –
Dimensional Fund Advisors
79
Dimensional Fund Advisors
Texas
$4K – – –
Citadel Advisors
80
Citadel Advisors
Florida
$2K -$68.2K -41,250 -97%
AA
81
Apriem Advisors
California
$1K – – –
GAM
82
Gemmer Asset Management
California
$1K +$1K +278 New
SM
83
Sabby Management
Florida
$582 +$36 +17,354 +7%
Manulife (Manufacturers Life Insurance)
84
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$160 +$2 +1,008 +1%
BCM
85
Bridgeway Capital Management
Texas
– -$1.65M -538,100 Closed
Invesco
86
Invesco
Georgia
– -$1.18M -386,210 Closed
D.E. Shaw & Co
87
D.E. Shaw & Co
New York
– -$468K -153,048 Closed
LPL Financial
88
LPL Financial
California
– -$155K -50,631 Closed
DIA
89
Denver Investment Advisors
Colorado
– -$120K -39,326 Closed
SIM
90
Strategic Investment Management
Virginia
– -$60K -19,777 Closed
Verition Fund Management
91
Verition Fund Management
Connecticut
– -$50K -16,489 Closed
QIM
92
Quantitative Investment Management
Virginia
– -$48K -15,700 Closed
T
93
TradeWorx
New Jersey
– -$47K -15,497 Closed
PA
94
Profund Advisors
Maryland
– -$37K -12,210 Closed
AL
95
Airain Ltd
Guernsey
– -$35K -11,600 Closed
ST
96
Spot Trading
Illinois
– -$33K -10,825 Closed
BRWA
97
B. Riley Wealth Advisors
Florida
– -$31.1K -10,180 Closed
VFA
98
Virtus Fund Advisers
Connecticut
– -$31K -10,071 Closed
FNYS
99
First New York Securities
New York
– -$16.2K -5,300 Closed
PNC Financial Services Group
100
PNC Financial Services Group
Pennsylvania
– -$15K -5,000 Closed
1 2 3
4
5

RXII Hedge Fund Activity: Q3 2014 in Review

85 of the 3,448 institutional investors tracked by Wall St. Rank reported a position in GALENA BIOPHARMA INC COM (RXII) for Q3 2014, worth a combined $44.3M — down 36% from $68.9M a quarter earlier.

Sellers outnumbered buyers: 17 funds closed out of RXII and 14 opened new positions — a net loss of 3 holders — while 27 trimmed existing stakes and 24 added.

The largest buyer was Morgan Stanley, adding an estimated $305K. The largest seller was Bridgeway Capital Management, exiting entirely with an estimated $1.65M sold.

  • 85 institutional investors held GALENA BIOPHARMA INC COM (RXII) as of Q3 2014, down from 90 in Q2 2014.
  • Funds reported $44.3M of GALENA BIOPHARMA INC COM stock for Q3 2014, down 36% quarter-over-quarter.
  • 14 funds opened new GALENA BIOPHARMA INC COM positions in Q3 2014 and 17 closed out, a net change of -3 holders.
  • The largest GALENA BIOPHARMA INC COM buyer in Q3 2014 was Morgan Stanley, an estimated $305K added.
  • The largest GALENA BIOPHARMA INC COM seller in Q3 2014 was Bridgeway Capital Management, an estimated $1.65M sold.

Based on aggregated 13F filings for Q3 2014.